1 day Ago By ABMN Staff
iSpecimen Inc. ( NASDAQ:ISPC – Get Free Report ) saw a significant decline in short interest during the month of August. As of August 31st, there was short interest totalling 326,400 shares, a decline of 8.
3% from the August 15th total of 355,900 shares. Based on an average trading volume of 1,970,000 shares, the days-to-cover ratio is currently 0.2 days.
Approximately 3.2% of the company’s stock are sold short. iSpecimen Stock Performance NASDAQ ISPC traded up $0.
32 during trading on Wednesday, reaching $5.52. 1,301,499 shares of the company’s stock were exchanged, compared to its average volume of 118,114.
The company has a 50 day moving average price of $0.46 and a two-hundred day moving average price of $0.36.
The stock has a market cap of $72.17 million, a P/E ratio of -4.31 and a beta of 1.
60. iSpecimen has a 1 year low of $3.41 and a 1 year high of $15.
38. iSpecimen ( NASDAQ:ISPC – Get Free Report ) last released its quarterly earnings data on Tuesday, August 6th. The company reported ($0.
19) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.28) by $0.09.
The company had revenue of $2.86 million during the quarter. iSpecimen had a negative net margin of 97.
03% and a negative return on equity of 115.36%. About iSpecimen iSpecimen Inc provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide.
Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, clinics, private practice groups, laboratories, blood centers, biobanks, clinical research sites, and cadaveric donation centers. Featured Articles Receive News & Ratings for iSpecimen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iSpecimen and related companies with MarketBeat.com's FREE daily email newsletter .
.
